Zkusit zdarma
Altimmune, Inc.

Altimmune, Inc.

ALT
Cena:
$ 2.90
-0.03 (-1.02%)
Valuace
70
Růst
23
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Here's Why You Should Add Altimmune Stock to Your Portfolio Now

Here's Why You Should Add Altimmune Stock to Your Portfolio Now

13:15 22-05-2026

ALT advances pemvidutide in MASH, AUD and ALD, with phase III plans and promising liver disease data...

Altimmune's Q1 Loss Narrower Than Expected, Revenues Nil

Altimmune's Q1 Loss Narrower Than Expected, Revenues Nil

11:46 14-05-2026

ALT posts a narrower Q1 loss as pemvidutide advances in MASH, AUD and ALD studies, with the cash run...

Altimmune, Inc. (ALT) Q1 2026 Earnings Call Transcript

Altimmune, Inc. (ALT) Q1 2026 Earnings Call Transcript

0:40 14-05-2026

Altimmune, Inc. (ALT) Q1 2026 Earnings Call Transcript...

Altimmune Q1 Earnings Call Highlights

Altimmune Q1 Earnings Call Highlights

10:08 13-05-2026

Altimmune NASDAQ: ALT said it has strengthened its balance sheet and is preparing to begin a global ...

Altimmune Announces First Quarter 2026 Financial Results and Business Update

Altimmune Announces First Quarter 2026 Financial Results and Business Update

7:30 13-05-2026

Initiation of PERFORMA Phase 3 MASH trial planned for second half 2026 $535 million in cash, cash eq...

Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026

Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026

7:15 13-05-2026

Abstract presenting 48-week IMPACT Phase 2b efficacy and safety data selected for inclusion in “Be...

Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026

Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026

7:30 06-05-2026

GAITHERSBURG, Md., May 06, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-s...

AI Financial Corporation (Formerly ALT5 Sigma) Begins Trading Under New Nasdaq Ticker Symbol 'AIFC'

AI Financial Corporation (Formerly ALT5 Sigma) Begins Trading Under New Nasdaq Ticker Symbol 'AIFC'

8:00 29-04-2026

Ticker Change Reflects the Company's Continued Evolution Across Payments, Tokenization and AI-Driven...

Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities

Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities

7:00 27-04-2026

$225 million funded at closing, with an additional $225 million warrant tranche Financing funds oper...

Altimmune, Inc. (NASDAQ:ALT) Receives Average Recommendation of “Moderate Buy” from Analysts

Altimmune, Inc. (NASDAQ:ALT) Receives Average Recommendation of “Moderate Buy” from Analysts

2:22 27-04-2026

Altimmune, Inc. (NASDAQ: ALT - Get Free Report) has been given an average rating of "Moderate Buy" b...

Altimmune Catalysts: 2026 Data Readouts and Financing Risks

Altimmune Catalysts: 2026 Data Readouts and Financing Risks

14:16 23-04-2026

ALT's 2026 hinges on pemvidutide, with key readouts, a phase III start, and funding strategy set to ...

ALT Stock: What Pemvidutide Means for MASH, AUD and ALD

ALT Stock: What Pemvidutide Means for MASH, AUD and ALD

14:10 23-04-2026

Altimmune bets big on pemvidutide across MASH, AUD and ALD, but with one drug driving value, upcomin...

Is Altimmune a Buy Before Phase III MASH Starts in 2026?

Is Altimmune a Buy Before Phase III MASH Starts in 2026?

14:06 23-04-2026

ALT heads into a high-stakes 2026 as pemvidutide drives key phase III and mid-stage catalysts that c...

Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities

Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities

23:25 22-04-2026

GAITHERSBURG, Md. , April 22, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinica...

Altimmune Announces Proposed Underwritten Public Offering of Securities

Altimmune Announces Proposed Underwritten Public Offering of Securities

16:19 22-04-2026

GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical...

ALT5 Sigma Corporation Announces Planned Rebrand to AI Financial Corporation (AiFi) and Nasdaq Ticker Change

ALT5 Sigma Corporation Announces Planned Rebrand to AI Financial Corporation (AiFi) and Nasdaq Ticker Change

8:00 22-04-2026

Rebrand aligns next phase of platform strategy across payments, tokenization, and AI- driven financi...

Altimmune Shareholders Approve All AGM Proposals, Boost Authorized Shares to 400M

Altimmune Shareholders Approve All AGM Proposals, Boost Authorized Shares to 400M

1:05 18-04-2026

Altimmune (NASDAQ: ALT) shareholders approved all proposals presented at the company's virtual annua...

ALT5 Sigma Corporation Reports Full Year 2025 Financial Results

ALT5 Sigma Corporation Reports Full Year 2025 Financial Results

8:00 13-04-2026

ALT5's core fintech platform continued to scale in 2025, supported by growth across payments, tradin...

Altimmune (NASDAQ:ALT) versus TNF Pharmaceuticals (NASDAQ:TNFA) Head-To-Head Comparison

Altimmune (NASDAQ:ALT) versus TNF Pharmaceuticals (NASDAQ:TNFA) Head-To-Head Comparison

1:35 05-04-2026

TNF Pharmaceuticals (NASDAQ: TNFA - Get Free Report) and Altimmune (NASDAQ: ALT - Get Free Report) a...

ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms

ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms

12:06 26-03-2026

Altimmune heads into a pivotal 2026 MASH race, betting its dual agonist pemvidutide can stand out in...

close

ALT5 SIGMA CORPORATION APPOINTS DR. ADEL ELMESSIRY TO BOARD OF DIRECTORS

12-02-2026
APPOINTMENT STRENGTHENS ALT5'S BOARD WITH EXPERTISE ACROSS AI INFRASTRUCTURE, DECENTRALIZED SYSTEMS,...
Více zde

ALTIMMUNE ANNOUNCES CLOSING OF $75 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK

29-01-2026
GAITHERSBURG, MD., JAN. 29, 2026 (GLOBE NEWSWIRE) -- ALTIMMUNE, INC. (NASDAQ: ALT), A LATE CLINICAL-...
Více zde

ALTIMMUNE ANNOUNCES PRICING OF $75 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK

27-01-2026
GAITHERSBURG, MD., JAN. 27, 2026 (GLOBE NEWSWIRE) -- ALTIMMUNE, INC. (NASDAQ: ALT), A LATE CLINICAL-...
Více zde

ALT5 SIGMA CORPORATION TO JOIN GLOBAL LEADERS AT INAUGURAL WORLD LIBERTY FORUM AT MAR-A-LAGO

27-01-2026
LAS VEGAS--(BUSINESS WIRE)--ALT5 SIGMA CORPORATION (NASDAQ: ALTS) (FRA:5AR1) (“ALT5” OR THE “C...
Více zde

ALT5 SIGMA CORPORATION LAUNCHES ALT5 AI TO POWER THE NEXT ERA OF ENTERPRISE AI—WHERE CRYPTO, COMPLIANCE AND AI PAYMENT RAILS CONVERGE

21-01-2026
LAS VEGAS--(BUSINESS WIRE)--ALT5 SIGMA CORPORATION (NASDAQ: ALTS) (FRA:5AR1) (“ALT5” OR THE “C...
Více zde

ALT5 SIGMA CORPORATION RESTORES COMPLIANCE WITH NASDAQ PERIODIC FILING REQUIREMENTS

14-01-2026
LAS VEGAS--(BUSINESS WIRE)--ALT5 SIGMA CORPORATION (THE “COMPANY” OR “ALT5”) (NASDAQ: ALTS)(...
Více zde

ALT5 SIGMA CORPORATION REPORTS Q3 2025 FINANCIAL RESULTS AND SIGNIFICANT MILESTONES

12-01-2026
LAS VEGAS--(BUSINESS WIRE)--ALT5 SIGMA CORPORATION (NASDAQ: ALTS) (THE “COMPANY”), A FINTECH COM...
Více zde

ALT5 SIGMA EXPECTS TO FILE ITS QUARTERLY REPORT ON FORM 10-Q FOR THE THIRD QUARTER 2025 IN THE COMING DAYS

05-01-2026
LAS VEGAS--(BUSINESS WIRE)--ALT5 SIGMA CORPORATION (THE “COMPANY” OR “ALT5”) (NASDAQ: ALTS)(...
Více zde

ALTIMMUNE RECEIVES FDA BREAKTHROUGH THERAPY DESIGNATION FOR PEMVIDUTIDE IN MASH

05-01-2026
ALIGNMENT ON PHASE 3 REGISTRATIONAL TRIAL PARAMETERS CONFIRMED FOLLOWING RECEIPT OF MINUTES FROM END...
Více zde

ALT5 SIGMA CONGRATULATES STRATEGIC PARTNER WORLD LIBERTY FINANCIAL ON USD1 STABLECOIN SURPASSING $3 BILLION MARKET CAPITALIZATION

30-12-2025
LAS VEGAS--(BUSINESS WIRE)--ALT5 SIGMA CORPORATION (THE “COMPANY” OR “ALT5”) (NASDAQ: ALTS)(...
Více zde

ALT5 INVESTIGATION: INVESTIGATION LAUNCHED INTO ALT5 SIGMA CORPORATION, ATTORNEYS ENCOURAGE INVESTORS AND POTENTIAL WITNESSES TO CONTACT LAW FIRM - ALTS

24-12-2025
SAN DIEGO, CALIFORNIA--(NEWSFILE CORP. - DECEMBER 24, 2025) - THE LAW FIRM OF ROBBINS GELLER RUDMAN ...
Více zde

ALTIMMUNE ANNOUNCES THAT PEMVIDUTIDE ACHIEVED KEY MEASURES OF SUCCESS AT 48 WEEKS IN IMPACT PHASE 2B MASH TRIAL

19-12-2025
IMPROVEMENTS OBSERVED IN KEY  NON-INVASIVE MARKERS OF FIBROSIS ACROSS TREATMENT ARMS VERSUS PLACEBO...
Více zde

ALT5 SIGMA CORPORATION ISSUES STOCKHOLDER LETTER FROM CEO TONY ISAAC

18-12-2025
LAS VEGAS--(BUSINESS WIRE)--ALT5 SIGMA CORPORATION (THE “COMPANY” OR “ALT5”) (NASDAQ: ALTS)(...
Více zde

ALT5 INVESTIGATION ALERT: INVESTIGATION LAUNCHED INTO ALT5 SIGMA CORPORATION, ATTORNEYS ENCOURAGE INVESTORS AND POTENTIAL WITNESSES TO CONTACT LAW FIRM - ALTS

11-12-2025
SAN DIEGO , DEC. 11, 2025 /PRNEWSWIRE/ --  ROBBINS GELLER RUDMAN & DOWD LLP IS INVESTIGATING POTENT...
Více zde

ALT5 SIGMA CORPORATION PROVIDES STRATEGIC OVERVIEW OF $WLFI TREASURY STRATEGY, USD1 STABLECOIN UTILITY AND ITS RELEVANCE TO THE COMPANY'S FUTURE PAYMENT INFRASTRUCTURE

11-12-2025
LAS VEGAS--(BUSINESS WIRE)--ALT5 SIGMA CORPORATION (THE “COMPANY,” “OUR” OR “ALT5”) (NAS...
Více zde

ALT5 ALERT: BRAGAR EAGEL & SQUIRE, P.C. IS INVESTIGATING ALT5 SIGMA CORP ON BEHALF OF ALT5 STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

09-12-2025
BRAGAR EAGEL & SQUIRE, P.C.  LITIGATION PARTNER  BRANDON WALKER  ENCOURAGES INVESTORS WHO SUFFERE...
Více zde

ALT5 SIGMA CORPORATION PROVIDES CORPORATE UPDATE

09-12-2025
LAS VEGAS--(BUSINESS WIRE)--ALT5 SIGMA CORPORATION (THE “COMPANY” OR “ALT5”) (NASDAQ: ALTS) ...
Více zde

ALT5 SIGMA RECEIVES EXPECTED NASDAQ NOTIFICATION REGARDING LATE FILING OF FORM 10-Q

02-12-2025
LAS VEGAS--(BUSINESS WIRE)--ALT 5 SIGMA CORPORATION (THE “COMPANY” OR “ALT5”) (NASDAQ: ALTS)...
Více zde

ALTIMMUNE ANNOUNCES CEO TRANSITION AND SUCCESSION PLAN

01-12-2025
ALTIMMUNE ANNOUNCES CEO TRANSITION AND SUCCESSION PLAN UNDER WHICH JERRY DURSO WILL ASSUME THE ROLE ...
Více zde

ALTIMMUNE TO PARTICIPATE IN THE PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE

26-11-2025
GAITHERSBURG, MD., NOV. 26, 2025 (GLOBE NEWSWIRE) -- ALTIMMUNE, INC. (NASDAQ: ALT), A LATE CLINICAL-...
Více zde

ALTIMMUNE ANNOUNCES PUBLICATION OF IMPACT PHASE 2B TRIAL DATA IN THE LANCET AND CONCURRENT LATE-BREAKING ORAL PRESENTATION AT AASLD THE LIVER MEETING® 2025

11-11-2025
24-WEEK DATA DEMONSTRATED SIGNIFICANT MASH RESOLUTION AND WEIGHT LOSS, AND STRONG EVIDENCE OF ANTI-F...
Více zde

ALTIMMUNE PRESENTS AI-BASED ANALYSIS OF LIVER FIBROSIS REDUCTION FROM IMPACT PHASE 2B TRIAL OF PEMVIDUTIDE IN MASH IN LATE-BREAKING POSTER AT AASLD THE LIVER MEETING® 2025

07-11-2025
AI-BASED DIGITAL PATHOLOGY ANALYSIS PROVIDES HIGH-RESOLUTION QUANTIFICATION OF HEPATIC FIBROSIS AND ...
Více zde

ALTIMMUNE ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS AND BUSINESS UPDATES

06-11-2025
48-WEEK DATA FROM PHASE 2B IMPACT TRIAL OF PEMVIDUTIDE IN MASH EXPECTED BEFORE YEAR END END-OF-PHASE...
Více zde

ALTIMMUNE TO PARTICIPATE IN TWO UPCOMING INVESTOR CONFERENCES

05-11-2025
GAITHERSBURG, MD., NOV. 05, 2025 (GLOBE NEWSWIRE) -- ALTIMMUNE, INC. (NASDAQ: ALT), A LATE CLINICAL-...
Více zde

ALTIMMUNE ANNOUNCES EARLY COMPLETION OF ENROLLMENT IN RECLAIM PHASE 2 TRIAL EVALUATING PEMVIDUTIDE IN ALCOHOL USE DISORDER

03-11-2025
ENROLLMENT COMPLETED AHEAD OF SCHEDULE, UNDERSCORING STRONG INTEREST FROM PATIENT COMMUNITY IN A POT...
Více zde

ALTIMMUNE TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON NOVEMBER 6, 2025

30-10-2025
GAITHERSBURG, MD., OCT. 30, 2025 (GLOBE NEWSWIRE) -- ALTIMMUNE, INC. (NASDAQ: ALT), A LATE CLINICAL-...
Více zde

ALTIMMUNE TO PRESENT PHASE 2B IMPACT DATA ON PEMVIDUTIDE IN MASH IN LATE-BREAKING ORAL PODIUM PRESENTATION AND LATE-BREAKING POSTER AT AASLD THE LIVER MEETING® 2025

20-10-2025
ORAL PRESENTATION TO HIGHLIGHT 24-WEEK EFFICACY AND SAFETY DATA POSTER TO FEATURE RESULTS OF AI-BASE...
Více zde

ALT5 SIGMA TREASURY STRATEGY SUPPORTED BY WORLD LIBERTY FINANCIAL'S INTERNATIONAL EXPANSION AND $WFLI TOKEN BURN

14-10-2025
LAS VEGAS--(BUSINESS WIRE)--ALT5 SIGMA CORPORATION (THE "COMPANY," "OUR" OR "ALT5") (NASDAQ: ALTS) (...
Více zde

ALTIMMUNE ALERT: BRAGAR EAGEL & SQUIRE, P.C. IS INVESTIGATING ALTIMMUNE, INC. ON BEHALF OF LONG-TERM STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

08-10-2025
BRAGAR EAGEL & SQUIRE, P.C.  LITIGATION PARTNER  BRANDON WALKER  ENCOURAGES INVESTORS WHO SUFFERE...
Více zde

ALT5 SIGMA ISSUES LETTER TO STOCKHOLDERS

08-10-2025
LAS VEGAS--(BUSINESS WIRE)--ALT5 SIGMA CORPORATION (THE "COMPANY," "OUR" OR "ALT5") (NASDAQ: ALTS) (...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-03 00:00:008-KStáhnout
2026-01-28 00:00:008-KStáhnout
2025-12-19 00:00:008-KStáhnout
2025-12-01 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-10-03 01:00:008-KStáhnout
2025-10-03 00:00:008-KStáhnout
2025-09-25 01:00:008-KStáhnout
2025-09-25 00:00:008-KStáhnout
2025-08-12 01:00:008-KStáhnout
2025-08-12 01:00:0010-QStáhnout
2025-08-12 00:00:008-KStáhnout
2025-08-12 00:00:0010-QStáhnout
2025-06-26 01:00:008-KStáhnout
2025-06-26 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 01:00:0010-QStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-13 00:00:0010-QStáhnout
2025-03-13 00:00:008-KStáhnout
2025-03-12 23:00:008-KStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2025-02-25 00:00:008-KStáhnout
2025-02-24 23:00:008-KStáhnout
2024-12-11 00:00:008-KStáhnout
2024-12-10 23:00:008-KStáhnout
2024-11-12 00:00:008-KStáhnout
2024-11-12 00:00:0010-QStáhnout
2024-11-11 23:00:008-KStáhnout
2024-11-11 23:00:0010-QStáhnout
2024-09-26 01:00:008-KStáhnout
2024-09-26 00:00:008-KStáhnout
2024-08-15 01:00:008-KStáhnout
2024-08-15 00:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-06-26 01:00:008-KStáhnout
2024-06-26 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-03-27 00:00:008-KStáhnout
2024-03-27 00:00:0010-KStáhnout
2024-03-26 23:00:008-KStáhnout
2024-03-26 23:00:0010-KStáhnout
2023-11-30 00:00:008-KStáhnout
2023-11-29 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-09-28 01:00:008-KStáhnout
2023-09-28 00:00:008-KStáhnout
2023-08-10 01:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:008-KStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-05-11 01:00:008-KStáhnout
2023-05-11 01:00:0010-QStáhnout
2023-05-11 00:00:008-KStáhnout
2023-05-11 00:00:0010-QStáhnout
2023-03-27 01:00:008-KStáhnout
2023-03-27 00:00:008-KStáhnout
2023-03-21 00:00:008-KStáhnout
2023-03-20 23:00:008-KStáhnout
2023-02-28 00:00:008-KStáhnout
2023-02-28 00:00:0010-KStáhnout
2023-02-27 23:00:008-KStáhnout
2023-02-27 23:00:0010-KStáhnout
2022-12-20 00:00:008-KStáhnout
2022-12-19 23:00:008-KStáhnout
2022-11-10 00:00:008-KStáhnout
2022-11-10 00:00:0010-QStáhnout
2022-11-09 23:00:008-KStáhnout
2022-11-09 23:00:0010-QStáhnout
2022-09-29 01:00:008-KStáhnout
2022-09-29 00:00:008-KStáhnout
2022-09-14 01:00:008-KStáhnout
2022-09-14 00:00:008-KStáhnout
2022-08-11 01:00:008-KStáhnout
2022-08-11 01:00:0010-QStáhnout
2022-08-11 00:00:008-KStáhnout
2022-08-11 00:00:0010-QStáhnout
2022-05-12 01:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:008-KStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-03-15 00:00:008-KStáhnout
2022-03-15 00:00:0010-KStáhnout
2022-03-14 23:00:008-KStáhnout
2022-03-14 23:00:0010-KStáhnout
2021-12-17 00:00:008-KStáhnout
2021-12-16 23:00:008-KStáhnout
2021-12-13 00:00:008-KStáhnout
2021-12-12 23:00:008-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-09 00:00:0010-QStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-08 23:00:0010-QStáhnout
2021-09-28 01:00:008-KStáhnout
2021-09-28 00:00:008-KStáhnout
2021-09-24 01:00:008-KStáhnout
2021-09-24 00:00:008-KStáhnout
2021-08-10 01:00:008-KStáhnout
2021-08-10 01:00:0010-QStáhnout
2021-08-10 00:00:008-KStáhnout
2021-08-10 00:00:0010-QStáhnout
2021-06-29 01:00:008-KStáhnout
2021-06-29 00:00:008-KStáhnout
2021-06-16 01:00:008-KStáhnout
2021-06-16 00:00:008-KStáhnout
2021-05-17 01:00:008-KStáhnout
2021-05-17 01:00:0010-QStáhnout
2021-05-17 00:00:008-KStáhnout
2021-05-17 00:00:0010-QStáhnout
2021-04-01 01:00:008-KStáhnout
2021-04-01 00:00:008-KStáhnout
2021-03-12 00:00:008-KStáhnout
2021-03-11 23:00:008-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-25 00:00:0010-KStáhnout
2021-02-24 23:00:008-KStáhnout
2021-02-24 23:00:0010-KStáhnout
2020-12-23 00:00:008-KStáhnout
2020-12-22 23:00:008-KStáhnout
2020-11-09 00:00:008-KStáhnout
2020-11-09 00:00:0010-QStáhnout
2020-11-08 23:00:008-KStáhnout
2020-11-08 23:00:0010-QStáhnout
2020-09-25 01:00:008-KStáhnout
2020-09-25 00:00:008-KStáhnout
2020-08-11 01:00:008-KStáhnout
2020-08-11 01:00:0010-QStáhnout
2020-08-11 00:00:008-KStáhnout
2020-08-11 00:00:0010-QStáhnout
2020-07-16 01:00:008-KStáhnout
2020-07-16 00:00:008-KStáhnout
2020-07-13 01:00:008-KStáhnout
2020-07-13 00:00:008-KStáhnout
2020-06-01 01:00:008-KStáhnout
2020-06-01 00:00:008-KStáhnout
2020-05-13 01:00:008-KStáhnout
2020-05-13 01:00:0010-QStáhnout
2020-05-13 00:00:008-KStáhnout
2020-05-13 00:00:0010-QStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 00:00:008-KStáhnout
2020-04-08 01:00:008-KStáhnout
2020-04-08 00:00:008-KStáhnout
2020-03-27 00:00:008-KStáhnout
2020-03-27 00:00:0010-KStáhnout
2020-03-26 23:00:008-KStáhnout
2020-03-26 23:00:0010-KStáhnout
2019-11-13 00:00:008-KStáhnout
2019-11-13 00:00:0010-QStáhnout
2019-11-12 23:00:008-KStáhnout
2019-11-12 23:00:0010-QStáhnout
2019-10-01 01:00:008-KStáhnout
2019-10-01 00:00:008-KStáhnout
2019-08-21 01:00:008-KStáhnout
2019-08-21 00:00:008-KStáhnout
2019-08-13 01:00:008-KStáhnout
2019-08-13 01:00:0010-QStáhnout
2019-08-13 00:00:008-KStáhnout
2019-08-13 00:00:0010-QStáhnout
2019-07-15 01:00:008-KStáhnout
2019-07-15 00:00:008-KStáhnout
2019-07-09 01:00:008-KStáhnout
2019-07-09 00:00:008-KStáhnout
2019-06-21 01:00:008-KStáhnout
2019-06-21 00:00:008-KStáhnout
2019-06-12 01:00:008-KStáhnout
2019-06-12 00:00:008-KStáhnout
2019-06-07 01:00:008-KStáhnout
2019-06-07 00:00:008-KStáhnout
2019-05-14 01:00:008-KStáhnout
2019-05-14 01:00:0010-QStáhnout
2019-05-14 00:00:008-KStáhnout
2019-05-14 00:00:0010-QStáhnout
2019-04-01 01:00:008-KStáhnout
2019-04-01 01:00:0010-KStáhnout
2019-04-01 00:00:008-KStáhnout
2019-04-01 00:00:0010-KStáhnout
2019-03-15 00:00:008-KStáhnout
2019-03-14 23:00:008-KStáhnout
2019-03-11 00:00:008-KStáhnout
2019-03-10 23:00:008-KStáhnout
2019-03-08 00:00:008-KStáhnout
2019-03-07 23:00:008-KStáhnout
2018-12-03 00:00:008-KStáhnout
2018-12-02 23:00:008-KStáhnout
2018-11-30 00:00:008-KStáhnout
2018-11-29 23:00:008-KStáhnout
2018-11-27 00:00:008-KStáhnout
2018-11-26 23:00:008-KStáhnout
2018-11-13 00:00:008-KStáhnout
2018-11-13 00:00:0010-QStáhnout
2018-11-12 23:00:008-KStáhnout
2018-11-12 23:00:0010-QStáhnout
2018-10-22 01:00:008-KStáhnout
2018-10-22 00:00:008-KStáhnout
2018-10-09 01:00:008-KStáhnout
2018-10-09 00:00:008-KStáhnout
2018-10-01 01:00:008-KStáhnout
2018-10-01 00:00:008-KStáhnout
2018-09-25 01:00:008-KStáhnout
2018-09-25 00:00:008-KStáhnout
2018-09-24 01:00:008-KStáhnout
2018-09-24 00:00:008-KStáhnout
2018-09-13 01:00:008-KStáhnout
2018-09-13 00:00:008-KStáhnout
2018-09-12 01:00:008-KStáhnout
2018-09-12 00:00:008-KStáhnout
2018-09-04 01:00:008-KStáhnout
2018-09-04 00:00:008-KStáhnout
2018-08-31 01:00:008-KStáhnout
2018-08-31 00:00:008-KStáhnout
2018-08-14 01:00:008-KStáhnout
2018-08-14 01:00:0010-QStáhnout
2018-08-14 00:00:008-KStáhnout
2018-08-14 00:00:0010-QStáhnout
2018-07-16 01:00:008-KStáhnout
2018-07-16 00:00:008-KStáhnout
2018-06-25 01:00:008-KStáhnout
2018-06-25 00:00:008-KStáhnout
2018-06-22 01:00:008-KStáhnout
2018-06-22 00:00:008-KStáhnout
2018-05-18 01:00:008-KStáhnout
2018-05-18 00:00:008-KStáhnout
2018-05-15 01:00:008-KStáhnout
2018-05-15 01:00:0010-QStáhnout
2018-05-15 00:00:008-KStáhnout
2018-05-15 00:00:0010-QStáhnout
2018-05-10 01:00:008-KStáhnout
2018-05-10 00:00:008-KStáhnout
2018-04-02 01:00:0010-KStáhnout
2018-04-02 00:00:0010-KStáhnout
2018-03-29 01:00:008-KStáhnout
2018-03-29 00:00:008-KStáhnout
2017-11-09 00:00:008-KStáhnout
2017-11-09 00:00:0010-QStáhnout
2017-11-08 23:00:008-KStáhnout
2017-11-08 23:00:0010-QStáhnout
2017-10-18 01:00:008-KStáhnout
2017-10-18 00:00:008-KStáhnout
2017-09-28 01:00:008-KStáhnout
2017-09-28 00:00:008-KStáhnout
2017-08-21 01:00:008-KStáhnout
2017-08-21 00:00:008-KStáhnout
2017-08-17 01:00:008-KStáhnout
2017-08-17 00:00:008-KStáhnout
2017-08-14 01:00:0010-QStáhnout
2017-08-14 00:00:0010-QStáhnout
2017-08-10 01:00:008-KStáhnout
2017-08-10 00:00:008-KStáhnout
2017-06-27 01:00:008-KStáhnout
2017-06-27 00:00:008-KStáhnout
2017-06-09 01:00:008-KStáhnout
2017-06-09 00:00:008-KStáhnout
2017-05-16 01:00:008-KStáhnout
2017-05-16 00:00:008-KStáhnout
2017-05-15 01:00:008-KStáhnout
2017-05-15 00:00:008-KStáhnout
2017-05-10 01:00:008-KStáhnout
2017-05-10 00:00:008-KStáhnout
2017-05-08 01:00:008-KStáhnout
2017-05-08 00:00:008-KStáhnout
2017-05-03 01:00:008-KStáhnout
2017-05-03 01:00:0010-QStáhnout
2017-05-03 00:00:008-KStáhnout
2017-05-03 00:00:0010-QStáhnout
2017-04-27 01:00:008-KStáhnout
2017-04-27 00:00:008-KStáhnout
2017-03-29 01:00:008-KStáhnout
2017-03-29 00:00:008-KStáhnout
2017-03-14 00:00:008-KStáhnout
2017-03-14 00:00:0010-KStáhnout
2017-03-13 23:00:008-KStáhnout
2017-03-13 23:00:0010-KStáhnout
2017-02-01 00:00:008-KStáhnout
2017-01-31 23:00:008-KStáhnout
2017-01-19 00:00:008-KStáhnout
2017-01-18 23:00:008-KStáhnout
2016-11-04 00:00:008-KStáhnout
2016-11-04 00:00:0010-QStáhnout
2016-11-03 23:00:008-KStáhnout
2016-11-03 23:00:0010-QStáhnout
2016-08-04 01:00:008-KStáhnout
2016-08-04 01:00:0010-QStáhnout
2016-08-04 00:00:008-KStáhnout
2016-08-04 00:00:0010-QStáhnout
2016-06-07 01:00:008-KStáhnout
2016-06-07 00:00:008-KStáhnout
2016-05-09 01:00:008-KStáhnout
2016-05-09 01:00:0010-QStáhnout
2016-05-09 00:00:008-KStáhnout
2016-05-09 00:00:0010-QStáhnout
2016-03-11 00:00:008-KStáhnout
2016-03-11 00:00:0010-KStáhnout
2016-03-10 23:00:008-KStáhnout
2016-03-10 23:00:0010-KStáhnout
2016-02-19 00:00:008-KStáhnout
2016-02-18 23:00:008-KStáhnout
2015-12-09 00:00:008-KStáhnout
2015-12-08 23:00:008-KStáhnout
2015-11-25 00:00:008-KStáhnout
2015-11-24 23:00:008-KStáhnout
2015-11-06 00:00:008-KStáhnout
2015-11-06 00:00:0010-QStáhnout
2015-11-05 23:00:008-KStáhnout
2015-11-05 23:00:0010-QStáhnout
2015-09-03 01:00:008-KStáhnout
2015-09-03 00:00:008-KStáhnout
2015-08-05 01:00:008-KStáhnout
2015-08-05 01:00:0010-QStáhnout
2015-08-05 00:00:008-KStáhnout
2015-08-05 00:00:0010-QStáhnout
2015-06-12 01:00:008-KStáhnout
2015-06-12 00:00:008-KStáhnout
2015-05-07 01:00:008-KStáhnout
2015-05-07 01:00:0010-QStáhnout
2015-05-07 00:00:008-KStáhnout
2015-05-07 00:00:0010-QStáhnout
2015-05-01 01:00:008-KStáhnout
2015-05-01 00:00:008-KStáhnout
2015-03-11 00:00:0010-KStáhnout
2015-03-10 23:00:0010-KStáhnout
2015-03-09 00:00:008-KStáhnout
2015-03-08 23:00:008-KStáhnout
2015-01-12 00:00:008-KStáhnout
2015-01-11 23:00:008-KStáhnout
2014-11-06 00:00:008-KStáhnout
2014-11-06 00:00:0010-QStáhnout
2014-11-05 23:00:008-KStáhnout
2014-11-05 23:00:0010-QStáhnout
2014-09-19 01:00:008-KStáhnout
2014-09-19 00:00:008-KStáhnout
2014-09-12 01:00:008-KStáhnout
2014-09-12 00:00:008-KStáhnout
2014-08-11 01:00:008-KStáhnout
2014-08-11 00:00:008-KStáhnout
2014-08-05 01:00:0010-QStáhnout
2014-08-05 00:00:0010-QStáhnout
2014-08-04 01:00:008-KStáhnout
2014-08-04 00:00:008-KStáhnout
2014-06-12 01:00:008-KStáhnout
2014-06-12 00:00:008-KStáhnout
2014-05-23 01:00:008-KStáhnout
2014-05-23 00:00:008-KStáhnout
2014-05-08 01:00:008-KStáhnout
2014-05-08 01:00:0010-QStáhnout
2014-05-08 00:00:008-KStáhnout
2014-05-08 00:00:0010-QStáhnout
2014-04-07 01:00:008-KStáhnout
2014-04-07 00:00:008-KStáhnout
2014-03-11 00:00:008-KStáhnout
2014-03-11 00:00:0010-KStáhnout
2014-03-10 23:00:008-KStáhnout
2014-03-10 23:00:0010-KStáhnout
2014-02-05 00:00:008-KStáhnout
2014-02-04 23:00:008-KStáhnout
2014-01-14 00:00:008-KStáhnout
2014-01-13 23:00:008-KStáhnout
2013-12-16 00:00:008-KStáhnout
2013-12-15 23:00:008-KStáhnout
2013-12-03 00:00:008-KStáhnout
2013-12-02 23:00:008-KStáhnout
2013-12-02 00:00:008-KStáhnout
2013-12-01 23:00:008-KStáhnout
2013-11-29 00:00:008-KStáhnout
2013-11-28 23:00:008-KStáhnout
2013-11-27 00:00:008-KStáhnout
2013-11-26 23:00:008-KStáhnout
2013-11-19 00:00:008-KStáhnout
2013-11-18 23:00:008-KStáhnout
2013-11-07 00:00:008-KStáhnout
2013-11-07 00:00:0010-QStáhnout
2013-11-06 23:00:008-KStáhnout
2013-11-06 23:00:0010-QStáhnout
2013-11-04 00:00:008-KStáhnout
2013-11-03 23:00:008-KStáhnout
2013-10-08 01:00:008-KStáhnout
2013-10-08 00:00:008-KStáhnout
2013-09-11 01:00:008-KStáhnout
2013-09-11 00:00:008-KStáhnout
2013-09-10 01:00:008-KStáhnout
2013-09-10 00:00:008-KStáhnout
2013-09-09 01:00:008-KStáhnout
2013-09-09 00:00:008-KStáhnout
2013-09-06 01:00:008-KStáhnout
2013-09-06 00:00:008-KStáhnout
2013-08-08 01:00:008-KStáhnout
2013-08-08 01:00:0010-QStáhnout
2013-08-08 00:00:008-KStáhnout
2013-08-08 00:00:0010-QStáhnout
2013-08-07 01:00:008-KStáhnout
2013-08-07 00:00:008-KStáhnout
2013-08-01 01:00:008-KStáhnout
2013-08-01 00:00:008-KStáhnout
2013-06-17 01:00:008-KStáhnout
2013-06-17 00:00:008-KStáhnout
2013-05-30 01:00:008-KStáhnout
2013-05-30 00:00:008-KStáhnout
2013-05-28 01:00:008-KStáhnout
2013-05-28 00:00:008-KStáhnout
2013-05-08 01:00:008-KStáhnout
2013-05-08 01:00:0010-QStáhnout
2013-05-08 00:00:008-KStáhnout
2013-05-08 00:00:0010-QStáhnout
2013-03-25 00:00:008-KStáhnout
2013-03-24 23:00:008-KStáhnout
2013-03-14 00:00:0010-KStáhnout
2013-03-13 23:00:0010-KStáhnout
2013-03-13 00:00:008-KStáhnout
2013-03-12 23:00:008-KStáhnout
2012-11-06 00:00:008-KStáhnout
2012-11-06 00:00:0010-QStáhnout
2012-11-05 23:00:008-KStáhnout
2012-11-05 23:00:0010-QStáhnout
2012-10-19 01:00:008-KStáhnout
2012-10-19 00:00:008-KStáhnout
2012-09-10 01:00:008-KStáhnout
2012-09-10 00:00:008-KStáhnout
2012-08-07 01:00:008-KStáhnout
2012-08-07 01:00:0010-QStáhnout
2012-08-07 00:00:008-KStáhnout
2012-08-07 00:00:0010-QStáhnout
2012-06-28 01:00:008-KStáhnout
2012-06-28 00:00:008-KStáhnout
2012-05-10 01:00:0010-QStáhnout
2012-05-10 00:00:0010-QStáhnout
2012-05-08 01:00:008-KStáhnout
2012-05-08 00:00:008-KStáhnout
2012-04-03 01:00:008-KStáhnout
2012-04-03 00:00:008-KStáhnout
2012-03-08 00:00:008-KStáhnout
2012-03-08 00:00:0010-KStáhnout
2012-03-07 23:00:008-KStáhnout
2012-03-07 23:00:0010-KStáhnout
2011-12-13 00:00:008-KStáhnout
2011-12-12 23:00:008-KStáhnout
2011-12-07 00:00:008-KStáhnout
2011-12-06 23:00:008-KStáhnout
2011-11-15 00:00:008-KStáhnout
2011-11-14 23:00:008-KStáhnout
2011-11-09 00:00:008-KStáhnout
2011-11-09 00:00:0010-QStáhnout
2011-11-08 23:00:008-KStáhnout
2011-11-08 23:00:0010-QStáhnout
2011-10-06 01:00:008-KStáhnout
2011-10-06 00:00:008-KStáhnout
2011-09-28 01:00:008-KStáhnout
2011-09-28 00:00:008-KStáhnout
2011-09-07 01:00:008-KStáhnout
2011-09-07 00:00:008-KStáhnout
2011-08-26 01:00:008-KStáhnout
2011-08-26 00:00:008-KStáhnout
2011-08-15 01:00:008-KStáhnout
2011-08-15 00:00:008-KStáhnout
2011-08-11 01:00:0010-QStáhnout
2011-08-11 00:00:0010-QStáhnout
2011-07-20 01:00:008-KStáhnout
2011-07-20 00:00:008-KStáhnout
2011-06-10 01:00:008-KStáhnout
2011-06-10 00:00:008-KStáhnout
2011-05-12 01:00:008-KStáhnout
2011-05-12 00:00:008-KStáhnout
2011-05-11 01:00:0010-QStáhnout
2011-05-11 00:00:0010-QStáhnout
2011-03-31 01:00:0010-KStáhnout
2011-03-31 00:00:0010-KStáhnout
2011-03-28 01:00:008-KStáhnout
2011-03-28 00:00:008-KStáhnout
2010-12-30 00:00:008-KStáhnout
2010-12-29 23:00:008-KStáhnout
2010-12-14 00:00:008-KStáhnout
2010-12-13 23:00:008-KStáhnout
2010-11-23 00:00:008-KStáhnout
2010-11-22 23:00:008-KStáhnout
2010-11-15 00:00:0010-QStáhnout
2010-11-14 23:00:0010-QStáhnout
2010-11-12 00:00:008-KStáhnout
2010-11-11 23:00:008-KStáhnout
2010-11-01 00:00:008-KStáhnout
2010-10-31 23:00:008-KStáhnout
2010-10-26 01:00:008-KStáhnout
2010-10-26 00:00:008-KStáhnout
2010-08-13 01:00:0010-QStáhnout
2010-08-13 00:00:0010-QStáhnout
2010-08-12 01:00:008-KStáhnout
2010-08-12 00:00:008-KStáhnout
2010-07-30 01:00:008-KStáhnout
2010-07-30 00:00:008-KStáhnout
2010-07-23 01:00:008-KStáhnout
2010-07-23 00:00:008-KStáhnout
2010-07-20 01:00:008-KStáhnout
2010-07-20 00:00:008-KStáhnout
2010-07-02 01:00:008-KStáhnout
2010-07-02 00:00:008-KStáhnout
2010-06-29 01:00:008-KStáhnout
2010-06-29 00:00:008-KStáhnout
2010-05-24 01:00:008-KStáhnout
2010-05-24 00:00:008-KStáhnout
2010-05-21 01:00:008-KStáhnout
2010-05-21 00:00:008-KStáhnout
2010-05-13 01:00:0010-QStáhnout
2010-05-13 00:00:0010-QStáhnout
2010-05-11 01:00:008-KStáhnout
2010-05-11 00:00:008-KStáhnout
2010-05-06 01:00:008-KStáhnout
2010-05-06 00:00:008-KStáhnout
2010-04-08 01:00:008-KStáhnout
2010-04-08 00:00:008-KStáhnout
2010-03-30 01:00:008-KStáhnout
2010-03-30 00:00:008-KStáhnout
2010-03-26 00:00:0010-KStáhnout
2010-03-25 23:00:0010-KStáhnout
2010-03-23 00:00:008-KStáhnout
2010-03-22 23:00:008-KStáhnout
2010-03-22 00:00:008-KStáhnout
2010-03-21 23:00:008-KStáhnout
2010-02-26 00:00:008-KStáhnout
2010-02-25 23:00:008-KStáhnout
2009-12-23 00:00:008-KStáhnout
2009-12-22 23:00:008-KStáhnout
2009-12-09 00:00:008-KStáhnout
2009-12-08 23:00:008-KStáhnout
2009-12-08 00:00:008-KStáhnout
2009-12-07 23:00:008-KStáhnout
2009-11-13 00:00:0010-QStáhnout
2009-11-12 23:00:0010-QStáhnout
2009-11-12 00:00:008-KStáhnout
2009-11-11 23:00:008-KStáhnout
2009-11-04 00:00:008-KStáhnout
2009-11-03 23:00:008-KStáhnout
2009-08-17 01:00:008-KStáhnout
2009-08-17 00:00:008-KStáhnout
2009-08-13 01:00:008-KStáhnout
2009-08-13 01:00:0010-QStáhnout
2009-08-13 00:00:008-KStáhnout
2009-08-06 01:00:008-KStáhnout
2009-08-06 00:00:008-KStáhnout
2009-07-30 01:00:008-KStáhnout
2009-07-30 00:00:008-KStáhnout
2009-07-16 01:00:008-KStáhnout
2009-07-16 00:00:008-KStáhnout
2009-06-23 00:00:008-KStáhnout
2009-05-15 00:00:008-KStáhnout
2009-04-30 00:00:008-KStáhnout
2009-04-28 00:00:008-KStáhnout
2009-04-23 00:00:008-KStáhnout
2009-04-16 00:00:008-KStáhnout
2009-03-31 00:00:0010-KStáhnout
2009-03-30 00:00:008-KStáhnout
2009-03-26 23:00:008-KStáhnout
2009-03-23 23:00:008-KStáhnout
preloader